CompoSecure Beats EBITDA Estimates But Analyst Cuts Price Forecast Amid Resolute Spin-Off And Growth Outlook
Analyst maintains Buy rating & lowers price target for CompoSecure Inc after Q4 revenue & EBITDA miss, but gains comfort with Resolute spin & Arculus profitability.
Ayr Wellness Inc.: AYR Wellness Reports Fourth Quarter and Full Year 2024 Results
AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) ("AYR" or the "Company"), a leading vertically integrated U.S. multi-state cannabis operator, is reporting financial ...
The Manila Times8h
AYR Wellness Reports Fourth Quarter and Full Year 2024 Results
MIAMI, March 06, 2025 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) ("AYR” or the "Company”), a leading ...
Parkland Corporation: Parkland Reports Fourth Quarter and Year-End 2024 Results; Initiates Review of Strategic Alternatives
Adjusted EBITDA1 of $428 million and full year Adjusted EBITDA of $1,690 million Fourth quarter and full year net earnings per share of $0.73 and $2.68 ...
Yext sees FY26 adjusted EBITDA $100M-$103M vs. $67M in FY25
EST Yext (YEXT) sees FY26 adjusted EBITDA $100M-$103M vs. $67M in FY25Discover the Best Stocks and Maximize Your Portfolio: See what ...